| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-14 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-14 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.27 | 3e-08 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.2 | 5e-08 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.3 | 6e-08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.19 | 8e-08 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 7e-07 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |